| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |


* Department of Inorganic Chemistry, Luleå University of Technology, Luleå, Sweden; and
Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0520 USA
Correspondence: Address reprint requests to Robert Tycko, National Institutes of Health, Building 5, Room 112, Bethesda, MD 20892-0520. Tel.: 301-402-8272; Fax: 301-496-0825; E-mail: tycko{at}helix.nih.gov.
| ABSTRACT |
|---|
|
|
|---|
and
backbone torsion angles between the labeled carbonyl sites, indicate non-ß-strand conformations at G25, S26, and G29. These results represent the first site-specific identification and characterization of non-ß-strand peptide conformations in an amyloid fibril. | INTRODUCTION |
|---|
|
|
|---|
More detailed and site-specific structural information has been difficult to obtain in amyloid fibrils because of their inherently noncrystalline and insoluble nature. Recently, several groups have used solid-state NMR techniques to characterize the supramolecular organization of the ß-sheets in amyloid fibrils, especially fibrils formed by the ß-amyloid (Aß) peptide associated with Alzheimer's disease (Antzutkin et al., 2000
; Antzutkin et al., 2002
; Balbach et al., 2002
; Petkova et al., 2002
) and several Aß fragments that serve as important model systems (Lansbury et al., 1995
; Benzinger et al., 1998
; Gregory et al., 1998
; Balbach et al., 2000
; Benzinger et al., 2000
; Burkoth et al., 2000
). One unanticipated result from solid-state NMR spectroscopy is that the ß-sheets in full-length Aß fibrils and in certain Aß fragment fibrils have a parallel, in-register structure (Benzinger et al., 1998
; Gregory et al., 1998
; Antzutkin et al., 2000
; Benzinger et al., 2000
; Burkoth et al., 2000
; Antzutkin et al., 2002
; Balbach et al., 2002
), whereas the ß-sheets in other Aß fragment fibrils have antiparallel structures (Lansbury et al., 1995
; Balbach et al., 2000
). Linewidths in solid-state NMR spectra of amyloid fibrils indicate a high degree of structural order in certain segments of the peptide sequence (Balbach et al., 2000
; Ishii, 2001
; Petkova et al., 2002
). In the case of full-length Aß fibrils, NMR linewidths and intermolecular dipole-dipole couplings indicate a disordered N-terminal segment of
10 residues (Balbach et al., 2002
; Petkova et al., 2002
), consistent with proteolysis data (Roher et al., 1993
; Saido et al., 1996
; Kheterpal et al., 2001
). 13C NMR chemical shifts have been used to identify specific peptide segments that form ß-strands in amyloid fibrils (Balbach et al., 2000
; Ishii, 2001
; Laws et al., 2001
; Petkova et al., 2002
).
Although the cross-ß structure is the predominant structural motif in amyloid fibrils, the dimensions of Aß fibrils suggest that the full-length peptide (Aß1-40, 40 residues; Aß1-42, 42 residues) adopts a structure that includes non-ß-strand conformations. The thinnest Aß1-40 and Aß1-42 fibrils observed in EM images have diameters of 6 ± 1 nm (Goldsbury et al., 2000
; Antzutkin et al., 2002
; Petkova et al., 2002
). The length of a ß-strand formed by M residues is approximately M x 0.34 nm. Given a 10-residue disordered N-terminal segment, a minimum diameter of 10 nm would be expected for Aß1-40 and Aß1-42 fibrils if the remainder of the peptide formed a single, continuous ß-strand. Circular dichroism spectra and secondary structure predictions based on the Aß amino acid sequence (Kirschner et al., 1987
; Hilbich et al., 1991
) have suggested a ß-turn in residues 23-30 (sequence DVGSNKGA). A ß-turn (Lazo and Downing, 1998
; George and Howlett, 1999
; Li et al., 1999
) or other non-ß-strand conformation (Tjernberg et al., 1999
) in this segment has been incorporated into several structural models. Measurements of enzymatic N-terminal proteolysis of Aß10-43 analogs with intramolecular disulfide linkages have been described as experimental support for a ß-turn encompassing residues 26-29 (Hilbich et al., 1991
).
In this paper, we report solid-state NMR data that demonstrate a non-ß-strand conformation in residues 24-30 of Aß1-40 fibrils and permit estimation of the
and
torsion angles, which define the peptide backbone conformation, at specific sites in this segment. The measurements were carried out on a series of samples in which pairs of 13C labels were introduced at consecutive backbone carbonyl sites. Three solid-state NMR techniques that place independent constraints on the
and
values between the two 13C labels were employed, namely constant-time finite-pulse radio-frequency-driven recoupling (fpRFDR-CT) (Ishii et al., 2001
), double-quantum chemical shift anistropy (DQCSA) spectroscopy (Blanco and Tycko, 2001
), and two-dimensional magic-angle spinning (2D MAS) exchange spectroscopy (Tycko et al., 1996
; Weliky and Tycko, 1996
; Tycko and Berger, 1999
). These techniques have previously been demonstrated on model compounds and applied in structural studies of a variety of peptides and proteins, including amyloid fibrils (Long and Tycko, 1998
; Weliky et al., 1999
; Balbach et al., 2000
; Blanco et al., 2001
; Antzutkin et al., 2002
; Balbach et al., 2002
). The results in this paper represent the first site-specific characterization of non-ß-sheet structure in an amyloid fibril.
| MATERIALS AND METHODS |
|---|
|
|
|---|
1 mM concentration (estimated from lyophilized peptide weight), adjustment to pH 7.4 by dropwise addition of dilute NaOH (from an initial pH
3.3), addition of 0.01% NaN3, and incubation at room temperature with gentle rocking for 1020 days. Solutions typically became noticeably viscous after several hours and gelled within several days. Incubated solutions were lyophilized for solid-state NMR measurements. The extent of fibrillization was assessed by one-dimensional (1D) 13C NMR spectroscopy (see below). Samples found to be incompletely fibrillized were reincubated for an additional 1020 days. Typical solid-state NMR samples were 10 mg. Samples were prepared with 13C labels at the backbone carbonyl sites of D23 and V24 (D23,V24-Aß1-40), V24 and G25 (V24,G25-Aß1-40), G25 and S26 (G25,S26-Aß1-40), K28 and G29 (K28,G29-Aß1-40), and G29 and A30 (sample G29,A30-Aß1-40). Amino acids with carboxyl 13C labels were purchased from Cambridge Isotopes Laboratories (Cambridge, MA) and Isotec (Miamisburg, OH) either with protecting groups required for peptide synthesis or as the bare amino acids. Fluorenylmethoxycarbonyl (FMOC) and side-chain protection reactions were performed by Midwest Biotech (Fishers, Indiana) when required. Because 13C-labeled asparagine could not be obtained, samples labeled at the backbone carbonyl site of N27 could not be prepared.
Protection of 13C-labeled aspartate, performed by Midwest Biotech, resulted in a mixture of the desired product (N-
-FMOC-L-aspartic acid ß-t-butyl ester) and an undesired isomer (N-
-FMOC-L-aspartic acid
-t-butyl ester) that incorporates into the peptide as ß-aspartate with a 13C-labeled side chain. The undesired isomer was present at a level of
20% in D23,V24-Aß1-40 after purification, based on 13C NMR (Fig. 1). Although substitution of ß-aspartate for aspartate may introduce a local structural perturbation in peptide chains containing the undesired isomer in the D23,V24-Aß1-40 sample, peptide chains containing this isomeric substitution did not contribute significantly to the fpRFDR-CT, DQCSA, and 2D MAS exchange measurements (because of the larger intramolecular 13C-13C distance and because of resolvable chemical shift differences) and hence did not affect any conclusions in this study regarding the conformation of Aß1-40 in amyloid fibrils. We emphasize that this impurity was present only in the D23,V24-Aß1-40 sample, and that data for this sample are not the basis for our report of non-ß-strand conformations in Aß1-40 fibrils (see below).
|
DQCSA and fpRFDR-CT NMR measurements were performed on Varian/Chemagnetics Infinity spectrometers operating at proton NMR frequencies of 400.6 MHz and 399.2 MHz, using Varian/Chemagnetics 3.2 mm MAS probes. DQCSA data were acquired as described by Blanco and Tycko (2001)
, using an MAS frequency of 5.0 kHz, DQ preparation and mixing periods of 6.4 ms, 13C
pulse lengths of 15.0 µs, and proton decoupling fields of 110 kHz during the RFDR sequence in these periods. DQ preparation and mixing periods were deliberately kept short to minimize possible effects of intermolecular couplings on the DQCSA data. The fpRFDR-CT data were acquired as described by Ishii et al. (2001)
, using an MAS frequency of 20.0 kHz, 13C
pulse lengths of 10.0 µs and proton decoupling fields of 110 kHz during the fpRFDR sequence, and with the parameters K = 3 and M + 2N = 96, in the notation of Ishii et al. Pulsed spin locking was used to enhance sensitivity in both fpRFDR-CT and DQCSA measurements, as described by Petkova and Tycko (2002)
. Two-dimensional MAS exchange measurements were performed on a Chemagnetics CMX spectrometer operating at a proton NMR frequency of 599.1 MHz, using the 2.5-mm MAS probe. Two-dimensional MAS exchange data were acquired as described by Weliky and Tycko (Tycko et al., 1996
; Weliky and Tycko, 1996
), using an MAS frequency of 3.78 kHz and 500-ms exchange periods. These data were processed in the manner of Hagemeyer et al. (Hagemeyer et al., 1989
; Tycko and Berger, 1999
). Radio-frequency pulses were actively synchronized with an MAS tachometer signal in fpRFDR-CT, DQCSA, and 2D MAS exchange measurements. Total experiment times were typically 8 h, 20 h, and 8 days for fpRFDR-CT, DQCSA, and 2D MAS exchange measurements, respectively.
NMR data analysis
DQCSA, fpRFDR-CT, and 2D MAS exchange data were analyzed by comparison with numerical simulations, performed with Fortran programs written specifically for this purpose (Tycko et al., 1996
; Blanco and Tycko, 2001
). Simulations of fpRFDR-CT data were carried out for a four-spin system (two carbonyl labels on two parallel chains), using an explicit evaluation of the quantum mechanical evolution operator for the full pulse sequence under MAS and including typical carbonyl CSA parameters as well as all dipole-dipole couplings. Four-spin fpRFDR-CT simulations for a full 5° grid in
and
with 864 powder orientations required
110 h of processor time (Pentium III, 1 GHz). Six-spin simulations (three carbonyl labels on three parallel chains) were approximately six times slower and produced fpRFDR-CT curves that were not significantly different. Simulations of DQCSA and 2D MAS exchange data were carried out for a two-spin system (two carbonyl labels on one chain). DQCSA simulations also used an explicit evaluation of the evolution operator for the full pulse sequence under MAS. Two-dimensional MAS exchange simulations used numerical evaluations of integral expressions for the crosspeak intensities (Tycko et al., 1996
; Tycko and Berger, 1999
). Effects of intermolecular couplings on 2D MAS exchange and DQCSA data were ignored for the following reasons: 1), 2D MAS exchange data are sensitive only to the relative orientations, and not the displacements, of the labeled carbonyl groups. Crosspeaks arise only from exchange between sites with different orientations. Assuming that each peptide chain is labeled at a site A and a site B and that neighboring chains in the cross-ß amyloid fibril structure are related by translational symmetry along the fibril axis, then exchange between sites A or sites B of neighboring chains generates no crosspeak intensity, whereas exchange between site A of one chain and site B of a neighboring chain generates the same crosspeak intensities as intramolecular exchange; 2), DQCSA data depend on the excitation of DQ coherences between carbonyl labels by an RFDR sequence (Gullion and Vega, 1992
; Bennett et al., 1998a
). The RFDR sequence only recouples two 13C sites under MAS if they have different isotropic shifts or different CSA tensor orientations. Again assuming translational symmetry, no DQ coherence can be directly excited between sites A or sites B of neighboring chains. Although DQ coherences can be excited between site A of one chain and site B of a neighboring chain, numerical four-spin simulations show that the contributions of such coherences to DQCSA signals are negligible under the conditions of our experiments.
In all simulations, a standard carbonyl 13C chemical shift anisotropy (CSA) tensor orientation was assumed, with the
33 axis perpendicular to the carbonyl plane and the
22 axis at 130° to the peptide C-N bond, as supported by experimental (Oas et al., 1987
; Teng et al., 1992
; Asakura et al., 1998
) and ab initio quantum chemical (Walling et al., 1997
) studies. CSA principal values were determined experimentally for each doubly labeled sample (see below).
The
2 deviation plotted in Fig. 4 has the general form:
![]() |
,
)} are the simulated values for the given torsion angles, N is the number of values,
rms is uncertainty in the experimental data due to the root-mean-squared noise in the experimental spectra, and
sim is uncertainty in the simulations. For DQCSA and 2D MAS exchange simulations,
sim was taken to be negligible compared with
rms. For fpRFDR-CT simulations,
sim was taken to be 5% of the maximum experimental data value, reflecting the high signal-to-noise of the experimental spectra and uncertainty about effects of intermolecular couplings beyond the four spins included in these simulations.
1(
,
) is a scaling factor calculated to minimize
2 for the given torsion angles, required because the intensity of the NMR signals is not measured on an absolute scale (Tycko et al., 1996
2(
,
) is an offset parameter, also calculated to minimize
2, that was included only in fpRFDR-CT analyses to account for contributions of natural-abundance 13C nuclei and residual unfibrillized Aß1-40 to the data. Good agreement between simulations and experiments corresponds to the condition
2
N.
|
| RESULTS |
|---|
|
|
|---|
-carbon signals into peaks at 52 ppm and 58 ppm. Two-dimensional 13C-13C exchange spectra of Aß1-40 samples with uniformly labeled residues (Petkova et al., 2002
-carbon signals of valine and isoleucine residues, which converge to this NMR frequency when ß-strands form concomitantly with fibrillization.
Spectra at MAS frequency
R = 3.75 kHz (left side of Fig. 1) show the spinning sideband patterns expected for carbonyl 13C labels. CSA principal values determined from these spectra (Herzfeld and Berger, 1980
) are given in Table 1. CSA principal values in Table 1 represent average values for the two labels in each sample except in the case of V24,G25-Aß1-40, where signals from the two labels could be deconvolved to permit determination of the principal values of the individual sites. All CSA values are consistent with the absence of large-amplitude motions of the carbonyl groups, i.e., a rigid peptide backbone.
|
1.5 ppm, whereas other sites (especially the G25 and G29 carbonyls) have larger linewidths or exhibit multiple, partially resolved lines. These lineshapes appear to indicate a mixture of local structural uniformity at some sites and structural heterogeneity at other sites in the segment from D23 through A30. For comparison, carbonyl 13C NMR linewidths for V12, L17, F20, V24, L34, and V39 in Aß1-40 fibril samples with single 13C labels have been found to be 1.33.0 ppm, with both F20 and L34 exhibiting two partially resolved carbonyl lines in 13C MAS spectra (Balbach et al., 2002
and
values, can not be determined in quantitative terms from these data.
Qualitative interpretation of structural data
As depicted in Fig. 2, 13C-labeling of two consecutive backbone carbonyl sites, at residues i-1 and i, permits the acquisition of solid-state NMR data that place constraints on the
and
torsion angles of residue i. The fpRFDR-CT technique measures the 13C-13C magnetic dipole-dipole coupling, which depends on the 13C-13C distance and therefore on the
angle. The DQCSA and 2D MAS exchange techniques measure the relative orientation of the two 13C CSA tensors, which depends on the relative orientation of the carbonyl groups and therefore on both
and
. For all residues in any ß-strand, the
and
values are approximately -140° ± 20° and 140° ± 20°, respectively. Because of the uniformity of the
and
values in a ß-strand, if one prepares a series of doubly carbonyl-labeled peptide samples with 13C labels in a ß-strand segment, one expects all samples in the series to yield nearly the same fpRFDR-CT, DQCSA, and 2D MAS exchange data. At a qualitative level, significant differences in these data from different samples would indicate a non-ß-strand conformation.
|
and
values in the segment from D23 through A30 are not uniform in Aß1-40 fibrils. In fpRFDR-CT measurements, one records the decay of the 13C NMR signal from the labeled sites with increasing dipolar dephasing time
D, due to the 13C-13C dipole-dipole couplings (Ishii et al., 2001
|. In Fig. 3 a, the most rapid fpRFDR-CT decay is observed for V24,G25-Aß1-40 fibrils, whereas the slowest decays are observed for D23,V24-Aß1-40 fibrils and G29,A30-Aß1-40 fibrils. In DQCSA measurements, one records the decay of the double-quantum filtered 13C NMR signal with increasing CSA evolution time
CSA. The decay rate of DQCSA signals depends on
and
in a complicated manner (Blanco and Tycko, 2001
= -60° and
= -65° (or
= 60° and
= 65°). The most rapid decays occur near
= ±180° or 0° and
= ±180° or 0°. In Fig. 3 b, the slowest DQCSA decay is observed for V24,G25-Aß1-40 fibrils, whereas the most rapid decay is observed for G29,A30-Aß1-40 fibrils.
|
|
and
(Tycko et al., 1996
Quantitative analysis of structural data
We analyze the fpRFDR-CT, DQCSA, and 2D MAS exchange data by simulating the data for all possible
,
pairs (in 5° increments) and plotting the dependence of the
2 deviation between experimental data and simulations on
and
. As previously demonstrated for DQCSA and 2D MAS measurements on model peptides of known structure (Tycko et al., 1996
; Weliky and Tycko, 1996
; Blanco and Tycko, 2001
), these simulations are sufficiently accurate that the absolute minimum value
min2 occurs within ±10° of the correct
and
values. In
2 plots for DQCSA and 2D MAS exchange data, additional local minima
loc2 are typically observed at other
and
values where the simulated data are similar to data for the correct
and
values. When
min2
loc2, for example due to insufficient signal-to-noise in the experiments, the correct
and
values can be determined by combining the results of independent techniques, which may then exhibit only a single common
2 minimum at the correct values (Bennett et al., 1998b
; Weliky et al., 1999
; Balbach et al., 2000
).
Representative
2 contour plots, for G25,S26-Aß1-40 fibrils and G29,A30-Aß1-40 fibrils, are shown in Fig. 4. Ideally, the best-fit (i.e., minimum
2) regions in the contour plots for fpRFDR-CT, DQCSA, and 2D MAS exchange data for a given sample would overlap in a single small area of the
,
plane, which would then indicate the correct values of
and
. As can be seen in Fig. 4, precise overlap of the best-fit regions for the DQCSA and 2D MAS exchange data is not observed. We attribute the absence of precise overlap to two factors: 1), Conformational heterogeneity in the non-ß-strand segment of fibrillized Aß1-40, as suggested by the relatively broad carbonyl 13C NMR lines for G25 and G29 discussed above. If a distribution of
and
values were significantly populated, one would expect
min2 for different techniques to shift in different directions, reducing or possibly eliminating the overlap; 2), Necessary approximations in the simulations, including the use of average CSA principal values for carbonyl 13C pairs with unresolved NMR signals, the assumption of a standard CSA tensor orientation for all carbonyl sites, and the neglect of intermolecular 13C-13C couplings (see Materials and Methods). Again, one would expect these approximations to produce different shifts in
min2 for different techniques.
To extract estimates of
and
from the
2 contour plots, the following procedure was therefore adopted: 1), A range of allowed
values was determined from the fpRFDR-CT contour plot, given by the condition
2 < 10; 2), The
2 minima in the DQCSA and 2D MAS exchange contour plots that lie within this
range and were closest together in the
,
plane were identified; 3), The average of the
and
values at these two minima was taken as an estimate of the correct values. Estimates of
and
determined with this procedure are summarized in Table 2. Backbone torsion angles for G25, S26, and G29 are found to be significantly different from ß-strand values, whereas torsion angles for V24 and A30 are consistent with a ß-strand conformation. These results are sensible in light of evidence from 13C NMR chemical shifts for ß-strand segments formed by residues 12-24 and 30-36 (Petkova et al., 2002
). Uncertainty in
and
due to conformational heterogeneity, suggested by the 1D 13C NMR spectra as discussed above, cannot be determined quantitatively from the data obtained to date.
|
. Therefore,
and only negative values of
are plotted in Fig. 4. For V24 and A30, the choice of signs for
and
in Table 2 is appropriate for a ß-strand conformation. For G25, S26, and G29, the sign choices in Table 2 were selected after molecular modeling (see below). Solid-state NMR data in this paper do not rule out the opposite sign choices for G25, S26, and G29. | DISCUSSION |
|---|
|
|
|---|
and
are indeterminate and because these data do not constrain
and
of N27 and K28. To permit visualization of the structural consequences of the non-ß-strand conformations at G25, S26, and G29, Fig. 5 shows structural models for residues 20-33, assuming typical ß-strand
and
values for residues 20-23, 27, 28, and 31-33. 13C chemical shift data support a ß-strand conformation at K28 (Petkova et al., 2002
and
of G25, S26, and G29. No energy minimization or other optimization of these models was performed.
Although all models in Fig. 5 are equally consistent with data in this paper, they are not all consistent with constraints imposed by supramolecular structure. 13C chemical shift data have established that the segments flanking residues 24-30 form ß-strands in Aß1-40 fibrils (Petkova et al., 2002
). Multiple quantum 13C NMR (Antzutkin et al., 2000
) and 13C-13C dipolar recoupling data (Balbach et al., 2002
) have established that these two ß-strands form separate parallel ß-sheets through intermolecular hydrogen bonding. To be compatible with a cross-ß fibril structure, the two ß-strands must be aligned so that all intermolecular hydrogen bonds are nearly parallel to a single axis (namely, the long axis of the fibril). Thus, all backbone carbonyl C-O bonds and amide N-H bonds in the ß-strands must be nearly parallel to one another. Only the models in Fig. 5, a and h, satisfy this requirement. Of these two, only the model in Fig. 5 a produces the net bend in the direction of the peptide backbone required by the experimentally observed diameters of Aß1-40 fibrils (see Introduction). For these reasons, the conformation in Fig. 5 a was used as a starting point for the recent development of a full structural model for Aß1-40 fibrils by constrained energy minimization (Petkova et al., 2002
). In addition, the backbone conformation in Fig. 5 a permits close contacts between the side-chain carboxylate and amino groups of D23 and K28, as supported by experimental measurements of 15N-13C dipole-dipole couplings that indicate internuclear distances on the order of 0.4 nm for these groups (Petkova et al., 2002
).
Comparison with earlier structural models
Several models for full-length Aß fibrils have included a ß-hairpin with a turn in residues 25-28 (George and Howlett, 1999
; Li et al., 1999
) or 24-27 (Lazo and Downing, 1998
). A true ß-hairpin requires intramolecular hydrogen bonding between ß-strands that flank the turn. However, 13C-13C dipolar recoupling data indicate intermolecular distances of 0.48 ± 0.05 nm (as required by intermolecular hydrogen bonding) between carbonyl or ß-carbon sites of V12, L17, F20, A21, V24, A30, L34, and V39 in Aß1-40 fibrils (Balbach et al., 2002
). Multiple quantum 13C NMR data have shown that the ß-carbons of both A21 and A30 must form groups of at least four with interatomic distances of
0.5 nm (Antzutkin et al., 2000
). These data rule out a true ß-hairpin with intramolecular hydrogen bonding. Thus, we believe that the non-ß-strand conformations in residues 24-30 simply create a bend or hinge between two separate parallel ß-sheets in Aß1-40 fibrils (Petkova et al., 2002
), reminiscent of the bends between ß-strands in ß-helical proteins (Yoder et al., 1993
; Emsley et al., 1996
) (although our data do not imply that Aß fibrils necessarily have the ß-helical structure suggested for amyloid fibrils by other groups (Lazo and Downing, 1998
; Perutz et al., 2002
; Wille et al., 2002
)). A similar structural role for these residues occurs in Aß fibril models proposed by Tjernberg et al. (1999)
and by Ma and Nussinov (2002)
.
Concluding remarks
One might expect the presence of a non-ß-strand segment in the middle of the Aß1-40 sequence to have implications for the effects of amino acid substitutions on fibril structure or stability. Although a number of mutagenesis studies have been reported, most of these deal with effects of substitutions outside the region addressed by our measurements (Fraser et al., 1992
; Hilbich et al., 1992
; Pike et al., 1995
; Esler et al., 1996
; Murakami et al., 2002
) or with amyloid fibrils formed by Aß fragments that may not be representative of the full-length peptide (Kirschner et al., 1987
; Fraser et al., 1994
; Wood et al., 1995
). A recent study by Morimoto et al. (2002)
has shown that substitutions of proline at residues 24 and 26 in Aß1-42 suppress aggregation and fibrillization, consistent with the fact that proline cannot adopt the
and
angles given for V24 and S26 in Table 2. Mutations associated with familial Alzheimer's disease, including A21G, E22Q, E22K, E22G, and D23N, occur near the non-ß-strand segment identified by our measurements. It is not yet clear whether kinetic, structural, thermodynamic, or purely biological factors lead to the association of these mutations with genetic predisposition to Alzheimer's disease.
Finally, the solid-state NMR data reported above demonstrate in a quantitative and site-specific manner that amyloid fibrils have structural complexity at the molecular level beyond the simple requirement of a cross-ß motif. Determination of the full molecular structures of amyloid fibrils entirely from experimental data remains an important and difficult challenge. Nonetheless, we believe that this challenge can be met through a combination of solid-state NMR measurements that probe supramolecular organization, identify ß-strand segments, characterize the conformation of non-ß-strand segments, and establish intermolecular and intramolecular contacts, with assistance from EM and other physical techniques.
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
ONA acknowledges support from the Swedish Foundation for International Cooperation in Research and Higher Education and from the Swedish Natural Science Research Council. Development of solid-state NMR methodology used in this work was supported in part by a grant to RT from the National Institutes of Health Intramural AIDS Targeted Antiviral Program.
Submitted on October 15, 2002; accepted for publication January 22, 2003.
| REFERENCES |
|---|
|
|
|---|
Antzutkin, O. N., R. D. Leapman, J. J. Balbach, and R. Tycko. 2002. Supramolecular structural constraints on Alzheimer's ß-amyloid fibrils from electron microscopy and solid state nuclear magnetic resonance. Biochemistry. 41:1543615450.[Medline]
Asakura, T., Y. Yamazaki, K. W. Seng, and M. Demura. 1998. Determination of the mutual orientation of the 15N and 13C NMR chemical shift tensors of 13C-15N double labeled model peptides for silk fibroin from the dipolar-coupled powder patterns. J. Mol. Struct. 446:179190.
Balbach, J. J., Y. Ishii, O. N. Antzutkin, R. D. Leapman, N. W. Rizzo, F. Dyda, J. Reed, and R. Tycko. 2000. Amyloid fibril formation by Aß1622, a seven-residue fragment of the Alzheimer's ß-amyloid peptide, and structural characterization by solid state NMR. Biochemistry. 39:1374813759.[Medline]
Balbach, J. J., A. T. Petkova, N. A. Oyler, O. N. Antzutkin, D. G. Gordon, S. C. Meredith, and R. Tycko. 2002. Supramolecular structure in full-length Alzheimer's ß-amyloid fibrils: evidence for a parallel ß-sheet organization from solid state NMR. Biophys. J. 83:12051216.
Bennett, A. E., C. M. Rienstra, J. M. Griffiths, W. G. Zhen, P. T. Lansbury, and R. G. Griffin. 1998a. Homonuclear radio frequency-driven recoupling in rotating solids. J. Chem. Phys. 108:94639479.
Bennett, A. E., D. P. Weliky, and R. Tycko. 1998b. Quantitative conformational measurements in solid state NMR by constant-time homonuclear dipolar recoupling. J. Am. Chem. Soc. 120:48974898.
Benzinger, T. L. S., D. M. Gregory, T. S. Burkoth, H. Miller-Auer, D. G. Lynn, R. E. Botto, and S. C. Meredith. 1998. Propagating structure of Alzheimer's ß-amyloid(1035) is parallel ß-sheet with residues in exact register. Proc. Natl. Acad. Sci. USA. 95:1340713412.
Benzinger, T. L. S., D. M. Gregory, T. S. Burkoth, H. Miller-Auer, D. G. Lynn, R. E. Botto, and S. C. Meredith. 2000. Two-dimensional structure of ß-amyloid(1035) fibrils. Biochemistry. 39:34913499.[Medline]
Blanco, F. J., S. Hess, L. K. Pannell, N. W. Rizzo, and R. Tycko. 2001. Solid state NMR data support a helix-loop-helix structural model for the N-terminal half of HIV-1 Rev in fibrillar form. J. Mol. Biol. 313:845859.[Medline]
Blanco, F. J., and R. Tycko. 2001. Determination of polypeptide backbone dihedral angles in solid state NMR by double quantum 13C chemical shift anisotropy measurements. J. Magn. Reson. 149:131138.
Burkoth, T. S., T. L. S. Benzinger, V. Urban, D. M. Morgan, D. M. Gregory, P. Thiyagarajan, R. E. Botto, S. C. Meredith, and D. G. Lynn. 2000. Structure of the ß-amyloid(1035) fibril. J. Am. Chem. Soc. 122:78837889.
Chiti, F., P. Webster, N. Taddei, A. Clark, M. Stefani, G. Ramponi, and C. M. Dobson. 1999. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl. Acad. Sci. USA. 96:35903594.
Emsley, P., I. G. Charles, N. F. Fairweather, and N. W. Isaacs. 1996. Structure of Bordetella pertussis virulence factor P.69 pertactin. Nature. 381:9092.[Medline]
Esler, W. P., E. R. Stimson, J. R. Ghilardi, Y. A. Lu, A. M. Felix, H. V. Vinters, P. W. Mantyh, J. P. Lee, and J. E. Maggio. 1996. Point substitution in the central hydrophobic cluster of a human ß-amyloid congener disrupts peptide folding and abolishes plaque competence. Biochemistry. 35:1391413921.[Medline]
Fraser, P. E., D. R. McLachlan, W. K. Surewicz, C. A. Mizzen, A. D. Snow, J. T. Nguyen, and D. A. Kirschner. 1994. Conformation and Fibrillogenesis of Alzheimer Aß peptides with selected substitution of charged residues. J. Mol. Biol. 244:6473.[Medline]
Fraser, P. E., J. T. Nguyen, H. Inouye, W. K. Surewicz, D. J. Selkoe, M. B. Podlisny, and D. A. Kirschner. 1992. Fibril formation by primate, rodent, and Dutch-hemorrhagic analogs of Alzheimer amyloid ß-protein. Biochemistry. 31:1071610723.[Medline]
George, A. R., and D. R. Howlett. 1999. Computationally derived structural models of the ß-amyloid found in Alzheimer's disease plaques and the interaction with possible aggregation inhibitors. Biopolymers. 50:733741.[Medline]
Goldsbury, C. S., S. Wirtz, S. A. Muller, S. Sunderji, P. Wicki, U. Aebi, and P. Frey. 2000. Studies on the in vitro assembly of Aß140: Implications for the search for Aß fibril formation inhibitors. J. Struct. Biol. 130:217231.[Medline]
Gregory, D. M., T. L. S. Benzinger, T. S. Burkoth, H. Miller-Auer, D. G. Lynn, S. C. Meredith, and R. E. Botto. 1998. Dipolar recoupling NMR of biomolecular self-assemblies: determining inter- and intrastrand distances in fibrilized Alzheimer's ß-amyloid peptide. Solid State Nucl. Magn. Reson. 13:149166.[Medline]
Gullion, T., and S. Vega. 1992. A simple magic angle spinning NMR experiment for the dephasing of rotational echoes of dipolar coupled homonuclear spin pairs. Chem. Phys. Lett. 194:423428.
Hagemeyer, A., K. Schmidt-Rohr, and H. W. Spiess. 1989. Two-dimensional nuclear magnetic resonance experiments for studying molecular order and dynamics in static and rotating solids. In Advances in Magnetic Resonance. W. S. Warren, editor. Academic Press, San Diego. 85130.
Herzfeld, J., and A. E. Berger. 1980. Sideband intensities in NMR spectra of samples spinning at the magic angle. J. Chem. Phys. 73:60216030.
Hilbich, C., B. Kisterswoike, J. Reed, C. L. Masters, and K. Beyreuther. 1991. Aggregation and secondary structure of synthetic amyloid ßA4 peptides of Alzheimer's disease. J. Mol. Biol. 218:149163.[Medline]
Hilbich, C., B. Kisterswoike, J. Reed, C. L. Masters, and K. Beyreuther. 1992. Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease ßA4 peptides. J. Mol. Biol. 228:460473.[Medline]
Inouye, H., P. E. Fraser, and D. A. Kirschner. 1993. Structure of ß-crystallite assemblies formed by Alzheimer ß-amyloid protein analogs: analysis by x-ray diffraction. Biophys. J. 64:502519.
Ishii, Y. 2001. 13C-13C dipolar recoupling under very fast magic angle spinning in solid-state nuclear magnetic resonance: applications to distance measurements, spectral assignments, and high-throughput secondary-structure determination. J. Chem. Phys. 114:84738483.
Ishii, Y., J. J. Balbach, and R. Tycko. 2001. Measurement of dipole-coupled lineshapes in a many-spin system by constant-time two-dimensional solid state NMR with high-speed magic-angle spinning. Chem. Phys. 266:231236.
Jimenez, J. L., E. J. Nettleton, M. Bouchard, C. V. Robinson, C. M. Dobson, and H. R. Saibil. 2002. The protofilament structure of insulin amyloid fibrils. Proc. Natl. Acad. Sci. USA. 99:91969201.
Kheterpal, I., A. Williams, C. Murphy, B. Bledsoe, and R. Wetzel. 2001. Structural features of the Aß amyloid fibril elucidated by limited proteolysis. Biochemistry. 40:1175711767.[Medline]
Kirschner, D. A., H. Inouye, L. K. Duffy, A. Sinclair, M. Lind, and D. J. Selkoe. 1987. Synthetic peptide homologous to ß-protein from Alzheimer's disease forms amyloid-like fibrils In vitro. Proc. Natl. Acad. Sci. USA. 84:69536957.
Koradi, R., M. Billeter, and K. Wuthrich. 1996. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14:5155.[Medline]
Lansbury, P. T., P. R. Costa, J. M. Griffiths, E. J. Simon, M. Auger, K. J. Halverson, D. A. Kocisko, Z. S. Hendsch, T. T. Ashburn, R. G. S. Spencer, B. Tidor, and R. G. Griffin. 1995. Structural model for the ß-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide. Nat. Struct. Biol. 2:990998.[Medline]
Laws, D. D., H. M. L. Bitter, K. Liu, H. L. Ball, K. Kaneko, H. Wille, F. E. Cohen, S. B. Prusiner, A. Pines, and D. E. Wemmer. 2001. Solid-state NMR studies of the secondary structure of a mutant prion protein fragment of 55 residues that induces neurodegeneration. Proc. Natl. Acad. Sci. USA. 98:1168611690.
Lazo, N. D., and D. T. Downing. 1998. Amyloid fibrils may be assembled from ß-helical protofibrils. Biochemistry. 37:17311735.[Medline]
Li, L. P., T. A. Darden, L. Bartolotti, D. Kominos, and L. G. Pedersen. 1999. An atomic model for the pleated ß-sheet structure of Aß amyloid protofilaments. Biophys. J. 76:28712878.
Long, H. W., and R. Tycko. 1998. Biopolymer conformational distributions from solid-state NMR:
-helix and 310-helix contents of a helical peptide. J. Am. Chem. Soc. 120:70397048.
Ma, B. Y., and R. Nussinov. 2002. Stabilities and conformations of Alzheimer's ß-amyloid peptide oligomers (Aß1622, Aß1635, and Aß1035): sequence effects. Proc. Natl. Acad. Sci. USA. 99:1412614131.
MacPhee, C. E., and C. M. Dobson. 2000. Formation of mixed fibrils demonstrates the generic nature and potential utility of amyloid nanostructures. J. Am. Chem. Soc. 122:1270712713.
Morimoto, A., K. Irie, K. Murakami, H. Ohigashi, M. Shindo, M. Nagao, T. Shimizu, and T. Shirasawa. 2002. Aggregation and neurotoxicity of mutant amyloid ß (Aß) peptides with proline replacement: importance of turn formation at positions 22 and 23. Biochem. Biophys. Res. Commun. 295:306311.[Medline]
Murakami, K., K. Irie, A. Morimoto, H. Ohigashi, M. Shindo, M. Nagao, T. Shimizu, and T. Shirasawa. 2002. Synthesis, aggregation, neurotoxicity, and secondary structure of various Aß142 mutants of familial Alzheimer's disease at positions 2123. Biochem. Biophys. Res. Commun. 294:510.[Medline]
Oas, T. G., C. J. Hartzell, T. J. McMahon, G. P. Drobny, and F. W. Dahlquist. 1987. The carbonyl 13C chemical shift tensors of five peptides determined from 15N dipole-coupled chemical shift powder patterns. J. Am. Chem. Soc. 109:59565962.
Perutz, M. F., J. T. Finch, J. Berriman, and A. Lesk. 2002. Amyloid fibers are water-filled nanotubes. Proc. Natl. Acad. Sci. USA. 99:55915595.
Petkova, A. T., Y. Ishii, J. J. Balbach, O. N. Antzutkin, R. D. Leapman, F. Delaglio, and R. Tycko. 2002. A structural model for Alzheimer's ß-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. USA. 99:1674216747.
Petkova, A. T., and R. Tycko. 2002. Sensitivity enhancement in structural measurements by solid state NMR through pulsed spin locking. J. Magn. Reson. 155:293299.[Medline]
Pike, C. J., A. J. Walencewicz-Wasserman, J. Kosmoski, D. H. Cribbs, C. G. Glabe, and C. W. Cotman. 1995. Structure-activity analyses of ß-amyloid peptides: contributions of the ß2535 region to aggregation and neurotoxicity. J. Neurochem. 64:253265.[Medline]
Roher, A. E., J. D. Lowenson, S. Clarke, C. Wolkow, R. Wang, R. J. Cotter, I. M. Reardon, H. A. Zurcherneely, R. L. Heinrikson, M. J. Ball, and B. D. Greenberg. 1993. Structural alterations in the peptide backbone of ß-amyloid core protein may account for its deposition and stability in Alzheimer's Disease. J. Biol. Chem. 268:30723083.
Saido, T. C., W. Yamao-Harigaya, T. Iwatsubo, and S. Kawashima. 1996. Amino- and carboxyl-terminal heterogeneity of ß-amyloid peptides deposited in human brain. Neurosci. Lett. 215:173176.[Medline]
Serpell, L. C., and J. M. Smith. 2000. Direct visualisation of the ß-sheet structure of synthetic Alzheimer's amyloid. J. Mol. Biol. 299:225231.[Medline]
Sipe, J. D. 1992. Amyloidosis. Annu. Rev. Biochem. 61:947975.[Medline]
Sunde, M., and C. C. F. Blake. 1998. From the globular to the fibrous state: protein structure and structural conversion in amyloid formation. Q. Rev. Biophys. 31:139.[Medline]
Sunde, M., L. C. Serpell, M. Bartlam, P. E. Fraser, M. B. Pepys, and C. C. F. Blake. 1997. Common core structure of amyloid fibrils by synchrotron x-ray diffraction. J. Mol. Biol. 273:729739.[Medline]
Teng, Q., M. Iqbal, and T. A. Cross. 1992. Determination of the 13C chemical-shift and 14N electric field gradient tensor orientations with respect to the molecular frame in a polypeptide. J. Am. Chem. Soc. 114:53125321.
Tjernberg, L. O., D. J. E. Callaway, A. Tjernberg, S. Hahne, C. Lilliehook, L. Terenius, J. Thyberg, and C. Nordstedt. 1999. A molecular model of Alzheimer amyloid ß-peptide fibril formation. J. Biol. Chem. 274:1261912625.
Tycko, R., and A. E. Berger. 1999. Dual processing of two-dimensional exchange data in magic angle spinning NMR of solids. J. Magn. Reson. 141:141147.[Medline]
Tycko, R., D. P. Weliky, and A. E. Berger. 1996. Investigation of molecular structure in solids by two-dimensional NMR exchange spectroscopy with magic angle spinning. J. Chem. Phys. 105:79157930.
Walling, A. E., R. E. Pargas, and A. C. de Dios. 1997. Chemical shift tensors in peptides: a quantum mechanical study. J. Phys. Chem. A. 101:72997303.
Weliky, D. P., A. E. Bennett, A. Zvi, J. Anglister, P. J. Steinbach, and R. Tycko. 1999. Solid state NMR evidence for an antibody-dependent conformation of the V3 loop of HIV-1 gp120. Nat. Struct. Biol. 6:141145.[Medline]
Weliky, D. P., and R. Tycko. 1996. Determination of peptide conformations by two-dimensional magic angle spinning NMR exchange spectroscopy with rotor synchronization. J. Am. Chem. Soc. 118:84878488.
Wille, H., M. D. Michelitsch, V. Guenebaut, S. Supattapone, A. Serban, F. E. Cohen, D. A. Agard, and S. B. Prusiner. 2002. Structural studies of the scrapie prion protein by electron crystallography. Proc. Natl. Acad. Sci. USA. 99:35633568.
Wood, S. J., R. Wetzel, J. D. Martin, and M. R. Hurle. 1995. Prolines and amyloidogenicity in fragments of the Alzheimers peptide ß/A4. Biochemistry. 34:724730.[Medline]
Yoder, M. D., N. T. Keen, and F. Jurnak. 1993. New domain motif: the structure of pectate lyase-C, a secreted plant virulence factor. Science. 260:15031507.
This article has been cited by other articles:
![]() |
Z. Bu, Y. Shi, D. J. E. Callaway, and R. Tycko Molecular Alignment within {beta}-Sheets in A{beta}14-23 Fibrils: Solid-State NMR Experiments and Theoretical Predictions Biophys. J., January 15, 2007; 92(2): 594 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Kinghorn, D. C. Crowther, L. K. Sharp, C. Nerelius, R. L. Davis, H. T. Chang, C. Green, D. C. Gubb, J. Johansson, and D. A. Lomas Neuroserpin Binds Abeta and Is a Neuroprotective Component of Amyloid Plaques in Alzheimer Disease J. Biol. Chem., September 29, 2006; 281(39): 29268 - 29277. [Abstract] [Full Text] |